GDF announces a 70% reduction for linezolidThis is projected to save up to US$30 million over the next 3 years.
TB & HIV Advocates Call for Joint ActionTB & HIV communities joined together UN headquarters in New York
World TB Day event in IndiaIndia is fast tracking access to diagnosis and treatment to reach TB targets by 2020
Global health leaders joined togetherto pledge their support to end TB by 2030
The Global Plan to End TB 2016-2020provides a roadmap for the fight against TB for a five-year period.
29 April - Meet the new Challenge Facility for Civil Society grantees!Meet the new Challenge Facility for Civil Society grantees!
29 April 2016, Geneva, Switzerland - The Stop TB Partnership’s Global Plan to Stop TB 2016-2020, challenges the traditional biomedical approaches to TB and calls for integrated and comprehensive responses to TB that are patient-centered and include strong partnerships with communities and civil society. To support community engagement the Stop TB Partnership launched a call for the seventh round of Challenge Facility for Civil Society (CFCS) grants in 2015. The CFCS provides grants to technically sound and innovative interventions to support the engagement of communities in national tuberculosis (TB) responses.
29 April - Stop TB Partnership's first ever Capacity Building Workshop with civil...Stop TB Partnership's first ever Capacity Building Workshop with civil society on procurement and supply chain management
29 April 2016 - The Stop TB Partnership this month, for the first time, organized a workshop specifically aimed to help civil society representatives from a selected group of countries better under-stand procurement and supply chain management (PSM) in order to increase access to TB drugs, diagnostics and other commodities. Experience has proven that a broad cooperation with commu-nities and civil society leads to more accurate data, which in turn increases accountability in pro-curement and supply chain management.
28 April - Stop TB Partnership's Global Drug Facility announces a 70% price reduction...Stop TB Partnership's Global Drug Facility announces a 70% price reduction for linezolid: another critical step towards achieving equitable access to MDR-TB treatment
28 April 2016 - Geneva, Switzerland - In another landmark achievement, the Global Drug Facility (GDF) of the Stop TB Partnership, has announced that the price of linezolid - a key medicine used to treat multidrug-resistant tuberculosis (MDR-TB) - will be cut by approximately 70% in 2016 compared to the previous year. This significant price reduction is projected to save up to US$ 30 million over the next 3 years, bringing us one step closer to making crucial MDR-TB medicines accessible to people that need them the most.
12 April - UN Zero Draft Political Declaration Calls for Joint Action on TB and AIDSUN Zero Draft Political Declaration Calls for Joint Action on TB and AIDS
20 April 2016 - The co-facilitators leading negotiations for the 2016 United Nations High-Level Meeting on Ending AIDS, the UN Permanent Representatives of Switzerland and Zambia, released the zero draft Political Declaration yesterday which will be negotiated and finalized by governments in the lead up to the 8-10th June High-Level Meeting in New York.
12 April - Have you still not submitted your nomination for the 2016 Kochon...Have you still not submitted your nomination for the 2016 Kochon Prize? Nominate an unsung hero!
12 April 2016 - Geneva, Switzerland - The Stop TB Partnership is pleased to announce that the deadline for the 2016 Kochon Prize’s call for nominations has been extended until Friday, 29 April.
07 April - TB and AIDS Advocates Call for Joint Action and Prioritizing...TB and AIDS Advocates Call for Joint Action and Prioritizing Communities in the TB and HIV Response at the United Nations in New York
07 April 2016 - New York, USA - Over 100 civil society voices from the TB and HIV communities joined together at UN Headquarters in New York yesterday to call for stronger integration of TB and HIV programs if the world is to reach the UN goals to End TB and HIV by 2030.
31 March - New fixed dose paediatric formulations now available for procurement...New fixed dose paediatric formulations now available for procurement through the Global Drug Facility
31 March 2016 - Geneva, Switzerland - The new fixed dose paediatric formulations are now available for procurement through the Global Drug Facility: rifampicin 75 mg + isoniazid 50 mg + pyrazinamide 150 mg and rifampicin 75 mg + isoniazid 50. The products dissolve in water, have a fruit flavour, and are simple to administer.
April 28 2016
April 27 2016
April 26 2016
March 24 2016
We set goals to fight TB globally. We grant funds to reach and treat people living with TB. We strive to raise the profile and understanding of TB. We bring the voice of TB communities to the fore. We procure drugs and diagnostics.
We work together with our partners to create a world without TB.
We are the Stop TB Partnership.